Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 2, 2012, Pages 1142-1145

  Grau, Thomas ^a   Selchow, Petra ^a   Tigges, Marcel ^b,c   Burri, Reto ^a   Gitzinger, Marc ^b,c   Böttger, Erik C ^a,d   Fussenegger, Martin ^b   Sander, Peter ^a,d  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c BIOVERSYS AG   (Switzerland)

^d Swiss National Center for Mycobacteria   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 PHENYLETHYL BUTYRATE; ANTIINFECTIVE AGENT; BUTYRIC ACID DERIVATIVE; ETHIONAMIDE; THIOACETAZONE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG POTENCY; DRUG RESISTANCE; GROWTH INHIBITION; MUTATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BUTYRATES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; ETHIONAMIDE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; OXYGENASES; PHENYLTHIOUREA; THIOACETAZONE;

EID: 84856074750     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05649-11     Document Type: Article

References (17)

1. Alahari A, et al. 2007. Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria. PLoS One 2:e1343.
2. Baulard AR, et al. 2000. Activation of the pro-drug ethionamide is regulated in mycobacteria. J. Biol. Chem. 275:28326-28331.
3. Bermudez LE, et al. 2003. Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice. Antimicrob. Agents Chemother. 47:2685-2687. (Pubitemid 36919482)
4. Bhowruth V, et al. 2006. Symmetrical and unsymmetrical analogues of isoxyl; active agents against Mycobacterium tuberculosis. Bioorg. Med. Chem. Lett. 16:4743-4747. (Pubitemid 44202597)
5. Brossier F, Veziris N, Truffot-Pernot C, Jarlier V, Sougakoff W. 2011. Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 55:355-360.
6. DeBarber AE, Mdluli K, Bosman M, Bekker LG, Barry CE III. 2000. Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 97:9677-9682. (Pubitemid 30650835)
7. Hollinrake K. 1968. Acute hepatic necrosis associated with ethionamide. Br. J. Dis. Chest 62:151-154.
8. Liav A, Angala SK, Brennan PJ, Jackson M. 2008. N-D-aldopentofuranosyl- N′-[p-(isoamyloxy)phenyl]-thiourea derivatives: potential anti-TB therapeutic agents. Bioorg. Med. Chem. Lett. 18:2649-2651. (Pubitemid 351503885)
9. Morlock GP, Metchock B, Sikes D, Crawford JT, Cooksey RC. 2003. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 47:3799-3805. (Pubitemid 37484992)
10. Muller B, et al. inhA promoter mutations: a gateway to extensively drug-resistant tuberculosis in South Africa? Int. J. Tuberc. Lung Dis. 15:344-351.
11. Springer B, Lucke K, Calligaris-Maibach R, Ritter C, Bottger EC. 2009. Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation. J. Clin. Microbiol. 47:1773-1780.
12. Vilcheze C, Jacobs WR, Jr. 2007. The mechanism of isoniazid killing: clarity through the scope of genetics. Annu. Rev. Microbiol. 61:35-50. (Pubitemid 350058198)
13. Wang F, et al. 2007. Mechanism of thioamide drug action against tuberculosis and leprosy. J. Exp. Med. 204:73-78. (Pubitemid 46148758)
14. Weber W, et al. 2008. A synthetic mammalian gene circuit reveals antituberculosis compounds. Proc. Natl. Acad. Sci. U. S. A. 105:9994-9998.
15. WHO. 2009. WHO TB factsheet. World Health Organization, Geneva, Switzerland. http://www.who.int/tb/publications/2009/tbfactsheet-2009-one-page. pdf.
16. Willand N, et al. 2009. Synthetic EthR inhibitors boost antituberculous activity of ethionamide. Nat. Med. 15:537-544.
17. Winder FG, Collins PB. 1970. Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis. J. Gen. Microbiol. 63:41-48.